The Dextroamphetamine XR Shortage Isn't Over Yet

If you take dextroamphetamine XR for ADHD or narcolepsy, you've probably been dealing with availability issues for months — or even years. The nationwide stimulant medication shortage that began in late 2022 continues to affect patients in 2026, and dextroamphetamine extended-release capsules remain one of the hardest medications to find.

This article gives you the latest update on the shortage status, explains why it's still happening, covers what dextroamphetamine XR costs in 2026, and lays out the most practical steps you can take to get your medication.

Is Dextroamphetamine XR Still in Shortage?

Yes. As of early 2026, dextroamphetamine extended-release capsules remain in active shortage according to the American Society of Health-System Pharmacists (ASHP). Multiple manufacturers have reported back orders on key strengths, particularly the 10 mg and 20 mg capsules.

The FDA's drug shortage database also continues to list amphetamine-based extended-release products as having limited availability. While some strengths (like 5 mg and 15 mg) are intermittently available, supply is inconsistent and varies significantly by region.

This shortage is part of a broader pattern affecting all amphetamine-based ADHD medications, including Adderall, Adderall XR, and mixed amphetamine salt products.

Why Is Dextroamphetamine XR Still Hard to Find?

The shortage is driven by several overlapping factors that haven't fully resolved:

DEA Production Quotas

The DEA limits how much of each Schedule II substance can be manufactured each year. While quotas have been increased, they still haven't caught up with the sustained surge in demand for ADHD medications.

Increased ADHD Diagnoses

ADHD diagnosis rates have risen sharply since the pandemic, driven by expanded telehealth access and greater awareness of the condition in adults. More patients means more prescriptions competing for a limited supply.

Manufacturing Delays

Several generic manufacturers have experienced production issues, raw material shortages, or regulatory delays. When one manufacturer falls behind, the entire market feels the squeeze because other manufacturers can't exceed their own quotas to compensate.

Distribution Bottlenecks

Even when medication is produced, it doesn't always reach the pharmacies that need it most. Wholesale distribution algorithms, regional demand patterns, and pharmacy-level ordering decisions all create pockets of scarcity. For a deeper dive, see our article on why dextroamphetamine XR is so hard to find.

How Much Does Dextroamphetamine XR Cost in 2026?

Pricing for dextroamphetamine extended-release capsules varies depending on your pharmacy, insurance coverage, and whether you use a discount card:

• Cash price (no insurance): $80 to $250 for 30 capsules, depending on the strength and pharmacy
• With a GoodRx or SingleCare coupon: As low as $32 for 30 capsules at select pharmacies
• With insurance: Typical copay ranges from $10 to $50, depending on your plan's formulary tier

The generic is significantly cheaper than brand alternatives like Mydayis ($300 to $400/month) and can be more affordable than brand-name Vyvanse. For detailed savings strategies, read our guide on how to save money on dextroamphetamine XR.

New Options and Developments in 2026

While no new dextroamphetamine XR brands have launched, there are some positive developments worth knowing about:

• Generic lisdexamfetamine (Vyvanse): Since Vyvanse went generic in 2023, lisdexamfetamine capsules have become more widely available and affordable. Since lisdexamfetamine is converted to dextroamphetamine in the body, it's a close pharmacological match.
• Increased DEA quotas: The DEA has continued to raise production quotas for amphetamine-based medications, though the effects take time to flow through the supply chain.
• Additional generic manufacturers: More companies have entered the generic amphetamine market, which should gradually improve supply.

How to Find Dextroamphetamine XR in Stock

Here are the most effective steps you can take right now:

1. Use Medfinder to search for pharmacies near you that have dextroamphetamine XR in stock. It's faster than calling individual pharmacies.
2. Try independent pharmacies — they often use different wholesalers than the national chains and may have supply when CVS and Walgreens don't.
3. Ask your pharmacist to back-order it. You may need to wait, but it puts you in the queue.
4. Refill early. Most states allow you to fill Schedule II prescriptions 1 to 2 days before your supply runs out.
5. Talk to your prescriber about alternatives if you can't find your medication for more than a week. Options include Vyvanse, Adderall XR, or methylphenidate ER.

For more detailed strategies, see our guide on how to find dextroamphetamine XR in stock near you.

Final Thoughts

The dextroamphetamine XR shortage is now more than three years old, and while progress is being made, patients are still feeling the impact in 2026. Knowing the current landscape — which strengths are affected, what the medication costs, and where to look — puts you in the best position to manage your treatment without interruption.

Bookmark Medfinder and check regularly, keep open communication with your prescriber, and know that you have options if dextroamphetamine XR isn't available. Your treatment matters, and the right medication is worth pursuing.